|
Volumn 1, Issue 4, 2000, Pages 208-210
|
Microvascular complications in cystic fibrosis-related diabetes mellitus: A case report
|
Author keywords
Amitriptyline; Ceftazidime; Cystic fibrosis (therapy); Diabetes mellitus (therapy); Diabetic angiopathies; Diabetic nephropathies; Diabetic retinopathy; Diclofenac; HLA DR antigens; Lisinopril
|
Indexed keywords
AMINOGLYCOSIDE;
AMITRIPTYLINE;
BETA LACTAM ANTIBIOTIC;
CEFTAZIDIME;
DICLOFENAC;
INSULIN;
LISINOPRIL;
ORAL ANTIDIABETIC AGENT;
TOBRAMYCIN;
ANTIINFECTIVE AGENT;
LACTAM;
ADULT;
ARTICLE;
CASE REPORT;
CYSTIC FIBROSIS;
DIABETES MELLITUS;
DIABETIC ANGIOPATHY;
DIABETIC NEPHROPATHY;
DIABETIC RETINOPATHY;
DISEASE EXACERBATION;
FEMALE;
GRAM NEGATIVE INFECTION;
HUMAN;
INFECTION CONTROL;
LUNG DISEASE;
NEPHROTOXICITY;
ORTHOSTATIC HYPOTENSION;
PREVALENCE;
SURVIVAL TIME;
BACTERIAL PNEUMONIA;
BLOOD;
KIDNEY FAILURE;
MICROCIRCULATION;
PATHOPHYSIOLOGY;
ADULT;
AMINOGLYCOSIDES;
ANTI-BACTERIAL AGENTS;
CYSTIC FIBROSIS;
DIABETES MELLITUS;
DIABETIC NEPHROPATHIES;
FEMALE;
HUMANS;
KIDNEY FAILURE;
LACTAMS;
MICROCIRCULATION;
PNEUMONIA, BACTERIAL;
PSEUDOMONAS INFECTIONS;
|
EID: 3242734743
PISSN: 15908577
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (6)
|